BioCentury | Aug 6, 2012
Finance

Burrill taps offshore

Burrill & Co. is already nearing an exit on one of a dozen investments made from a new $505 million fund that had a second close last week. G. Steven Burrill told BioCentury the undisclosed...
BioCentury | May 7, 2012
Finance

BG-12 deal keeps on giving

The former shareholders of Fumapharm AG could be looking forward to more than $2.5 billion in milestones if sales for multiple sclerosis treatment BG-12 from Biogen Idec Inc. live up to Wall Street expectations. Last...
BioCentury | Aug 17, 2009
Finance

Ebb & Flow

Domain Associates was in the process of planning its eighth fund when the market melted down last fall. The firm decided to go ahead anyway with a $700 million target, which would have matched the...
BC Extra | Aug 12, 2009
Top Story

Cumberland prices IPO

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) raised $85 million through the sale of 5 million shares at $17 in an IPO underwritten by UBS; Jefferies; Wells Fargo; and Morgan Joseph. The deal came in below the proposed...
BioCentury | Aug 3, 2009
Finance

Ebb & Flow

Cumberland Pharmaceuticals Inc. is hoping to capitalize on both the market upswing and the June FDA approval of its Caldolor IV ibuprofen to get an IPO out the door. The last substantial IPO was almost...
BioCentury | Jul 30, 2007
Finance

Ebb & Flow

Pharmion (PHRM) had its second bad week in a row, weighed down by the unanimous recommendation of FDA's Oncologic Drugs Advisory Committee last Tuesday against accelerated approval of Orplatna satraplatin from GPC Biotech (FSE:GPC; GPCB)....
BC Extra | Jul 23, 2007
Financial News

Cumberland amends IPO

Cumberland (Nashville, Tenn.) updated its IPO and hopes to sell 6.3 million shares at $14-$16. A $15 price would raise $93.8 million and value the company at $267.6 million. UBS; Jefferies; Wachovia; and Morgan Joseph...
BioCentury | May 7, 2007
Finance

Ebb & Flow

Five executives at MedImmune (MEDI) will be receiving more than $280 million when the $15.6 billion acquisition by AstraZeneca (LSE:AZN; AZN) closes. By comparison, the biotech sector raised a total of $566 million last week,...
BC Extra | May 3, 2007
Financial News

Cumberland files for IPO

Cumberland (Nashville, Tenn.) filed to raise up to $115 million in an IPO underwritten by UBS; Jefferies; Wachovia; and Morgan Joseph. Cumberland markets Acetadote intravenous N-acetylcysteine for acetaminophen poisoning; and Kristalose , a crystalline form of...
Items per page:
1 - 9 of 9